{"componentChunkName":"component---src-templates-uk-residents-non-hcp-video-pdf-template-js","path":"/UkResidents/Non-HCP/information-for-uk-patients","result":{"data":{"contentfulVideoPdfTemplate":{"spaceId":"qzd1spzkopy8","slug":"information-for-uk-patients","title":"Information for UK Patients on Alkindi®","bannerImage":{"file":{"url":"//images.ctfassets.net/qzd1spzkopy8/55WQY9dapl4XiL9bZoVpv8/0eb5b4748431939d01f2fde6df139543/united-kingdom-2405963_960_720.jpg"}},"BodyText":{"json":{"nodeType":"document","data":{},"content":[{"nodeType":"paragraph","data":{},"content":[{"nodeType":"text","value":"UK laws and regulations limit the amount of product information that we can provide to the public on our website, the information here is intended for patients treated with Alkindi and their carers.\n","marks":[],"data":{}}]},{"nodeType":"heading-3","data":{},"content":[{"nodeType":"text","value":"Alkindi Patient Information","marks":[],"data":{}}]},{"nodeType":"paragraph","data":{},"content":[{"nodeType":"text","value":"This page is specifically intended to support UK patients who have been prescribed Alkindi by their doctor. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the Patient Information Leaflet (PIL) provided with your medicine and which is reproduced here.\n\n","marks":[],"data":{}},{"nodeType":"hyperlink","data":{"uri":"https://images.ctfassets.net/qzd1spzkopy8/1HMo9wtDvgCrlwTO1ZOQZF/ad8a096d9693bd0b9cd897fe074f9434/Alkindi-UKGBNI_PIL__text_-effective_01October2025.pdf"},"content":[{"nodeType":"text","value":"Click here to see the Alkindi Patient Information Leaflet","marks":[],"data":{}}]},{"nodeType":"text","value":"","marks":[],"data":{}}]},{"nodeType":"paragraph","data":{},"content":[{"nodeType":"text","value":"\n\n","marks":[],"data":{}}]}]}},"bottomBodyText":{"json":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Patient Groups","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"For more information and support visit these useful sites: ","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://www.livingwithcah.com"},"content":[{"data":{},"marks":[],"value":"Livingwithcah.com","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://www.pituitary.org.uk/"},"content":[{"data":{},"marks":[],"value":"Pituitary.org.uk","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://www.addisonsdisease.org.uk/"},"content":[{"data":{},"marks":[],"value":"Addisonsdisease.org.uk","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"},{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"},{"data":{"uri":"https://childgrowthfoundation.org/"},"content":[{"data":{},"marks":[],"value":"Childgrowthfoundation.org","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"list-item"}],"nodeType":"unordered-list"},{"data":{},"content":[{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"}},"flag":{"file":{"url":"//images.ctfassets.net/qzd1spzkopy8/1i2CQ40dmm42wNVeF1BM7w/b59d0e6b4b97bba8857adfa3c2e8dcca/uk_flag-c775925db8c731b646d6186d7059423a.png"}},"video":{"file":{"url":"//videos.ctfassets.net/qzd1spzkopy8/14LDlNpH47cCW1ePnpkAD4/6e9247dd528d72171f430cedd2a00890/Alkindi_Administration_Video_UK_-_Version_5_-_Nov_2024-optimised.mp4"}},"videoPoster":{"file":{"url":"//images.ctfassets.net/qzd1spzkopy8/4FyFjaj065Xv9tN5SCIVl/45b49eaaa70d1ca2c36d2e8d34cb2173/Screenshot_2024-12-19_at_16.18.29.png"}},"videoSectionSideText":{"json":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Adverse events should be reported.\nReporting Forms and information can be\nfound at ","nodeType":"text"},{"data":{"uri":"https://yellowcard.mhra.gov.uk/"},"content":[{"data":{},"marks":[],"value":"www.mhra.gov.uk/yellowcard","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"Adverse Events should also be reported\nto Neurocrine on ","nodeType":"text"},{"data":{"uri":"mailto:adverseeventsEU@neurocine.com"},"content":[{"data":{},"marks":[],"value":"adverseeventsEU@neurocine.com","nodeType":"text"}],"nodeType":"hyperlink"},{"data":{},"marks":[],"value":"\n\n\n","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"\n\n","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"}},"videoSectionTopText":{"json":{"data":{},"content":[{"data":{},"content":[{"data":{},"marks":[],"value":"Alkindi - Administration video","nodeType":"text"}],"nodeType":"heading-3"},{"data":{},"content":[{"data":{},"marks":[],"value":"This video is intended for patients who have been prescribed Alkindi and provides a step-by-step administration guide.","nodeType":"text"}],"nodeType":"paragraph"},{"data":{},"content":[{"data":{},"marks":[],"value":"\n\n","nodeType":"text"}],"nodeType":"paragraph"}],"nodeType":"document"}},"parentMenu":{"title":"Administration Instructions for Neurocrine Patients","slug":"administration-instructions-for-neurocrine-patients"},"isPlaceholder":null}},"pageContext":{"slug":"information-for-uk-patients","spaceId":"qzd1spzkopy8"}},"staticQueryHashes":["3656863107","63159454"]}